Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Non Operating Income: 2022-2024

Historic Non Operating Income for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $7.4 million.

  • Lexeo Therapeutics' Non Operating Income rose 26.94% to $787,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $7.4 million for FY2024, which is 250.78% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Non Operating Income of $7.4 million as of FY2024, which was up 250.78% from $2.1 million recorded in FY2023.
  • Lexeo Therapeutics' Non Operating Income's 5-year high stood at $7.4 million during FY2024, with a 5-year trough of $1.2 million in FY2022.
  • Moreover, its 3-year median value for Non Operating Income was $2.1 million (2023), whereas its average is $3.6 million.
  • Data for Lexeo Therapeutics' Non Operating Income shows a peak YoY surged of 250.78% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Lexeo Therapeutics' Non Operating Income stood at $1.2 million in 2022, then skyrocketed by 72.00% to $2.1 million in 2023, then soared by 250.78% to $7.4 million in 2024.